Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease

Stem Cells

Volumn 29, Issue 2, 2011, Pages 251-262

  Sánchez, Laura ^a   Gutierrez Aranda, Iván ^a   Ligero, Gertrudis ^a   Rubio, Ruth ^a   Muñoz López, Martín ^a   García Pérez, José L ^a   Ramos, Verónica ^a   Real, Pedro J ^a   Bueno, Clara ^a   Rodríguez, René ^a   Delgado, Mario ^b   Menendez, Pablo ^a  

^a Instituto de Investigación Biomédica   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

hESC; Inflammatory bowel disease; iPS cells; MSCs; SMAD 2 3

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; SMAD2 PROTEIN; SMAD3 PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; COLITIS; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENTERITIS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PLURIPOTENT STEM CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WESTERN BLOTTING;

ANTIGENS, CD; BENZAMIDES; CELL DIFFERENTIATION; CELL LINE; DIOXOLES; EMBRYONIC STEM CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSION; INFLAMMATORY BOWEL DISEASES; MESENCHYMAL STEM CELLS; MULTIPOTENT STEM CELLS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TISSUE THERAPY;

IPS;

EID: 79952133599     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.569     Document Type: Article

References (49)

1. Menendez P, Bueno C, Wang L. Human embryonic stem cells: A journey beyond cell replacement therapies. Cytotherapy 2006;8:530-541. (Pubitemid 44869853)
2. Bueno C, Garcia-Castro J, Montes R et al. Human embryonic stem cells: A potential system for modeling infant leukemia harboring MLL-AF4 fusion gen. Drug Discov Today Dis Models 2008;4:53-60.
3. Menendez P, Bueno C, Wang L et al. Human embryonic stem cells: potential tool for achieving immunotolerance? Stem Cell Rev 2005;1:151-158.
4. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-327.
5. Friedenstein AJ, Chailakhyan RK, Latsinik NV et al. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 1974;17:331-340.
6. Garcia-Castro J, Trigueros C, Madrenas J et al. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 2008;12:2552-2565.
7. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
8. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-1822. (Pubitemid 40223708)
9. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48. (Pubitemid 34059216)
10. Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11:321-334. (Pubitemid 40542924)
11. Menendez P, Perez-Simon JA, Mateos MV et al. Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors. Br J Haematol 2002;119:135-143. (Pubitemid 35176513)
12. Menendez P, Prosper F, Bueno C et al. Sequential analysis of CD34+ and CD34- cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide. Leukemia 2001;15:430-439. (Pubitemid 32243777)
13. Barberi T, Willis LM, Socci ND et al. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. Plos Med 2005;2:e161.
14. Trivedi P, Hematti P. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Exp Hematol 2008;36:350-359.
15. Lorda-Diez CI, Montero JA, Martinez-Cue C et al. Transforming growth factors beta coordinate cartilage and tendon differentiation in the developing limb mesenchyme. J Biol Chem 2009;284:29988-29996.
16. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003;8:740-748. (Pubitemid 37288325)
17. Bendall SC, Stewart MH, Menendez P et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 2007;448:1015-1021. (Pubitemid 47345578)
18. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: Pleiotropic role in the regulation of hematopoiesis. Blood 2000;96:2022-2036.
19. Fortunel NO, Hatzfeld JA, Monier MN et al. Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol Res 2003;13:445-453.
20. Kim SJ, Letterio J. Transforming growth factor-beta signaling in normal and malignant hematopoiesis. Leukemia 2003;17:1731-1737.
21. Cortes JL, Sanchez L, Ligero G et al. Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos. Hum Reprod 2009;24:1844-1851.
22. Menendez P, Wang L, Chadwick K et al. Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45(neg)PFV hemogenic precursors. Mol Ther 2004;10:1109-1120. (Pubitemid 39625254)
23. Montes R, Ligero G, Sanchez L et al. Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: Distinct requirements for TGF-beta and IGF-II. Cell Res 2009;19:698-709.
24. Ramos-Mejia V, Melen GJ, Sanchez L et al. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate towards the hematopoietic lineage. Mol Ther 2010;18:2173-2181.
25. Ramos-Mejia V, Munoz-Lopez M, Garcia-Perez JL et al. iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res 2010;20:1092-1095.
26. Rodriguez R, Rubio R, Masip M et al. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia 2009;11:397-407.
27. Menendez P, Redondo O, Rodriguez A et al. Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry 1998;34:264-271.
28. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G et al. Embryonic stem cell-specific miR302-367 cluster: Human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008;28:6609-6619.
29. Menendez P, Catalina P, Rodriguez R et al. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med 2009;206:3131-3141.
30. Rubio R, Garcia-Castro J, Gutierrez-Aranda I et al. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res 2010;70:4185-4194.
31. Gonzalez MA, Gonzalez-Rey E, Rico L et al. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 2009;136:978-989.
32. Kim PG, Daley GQ. Application of induced pluripotent stem cells to hematologic disease. Cytotherapy 2009;11:980-990.
33. Gonzalez-Rey E, Anderson P, Gonzalez MA et al. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009;58:929-939.
34. Yanez R, Lamana ML, Garcia-Castro J et al. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006;24:2582-2591. (Pubitemid 44674320)
35. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533. (Pubitemid 37328672)
36. Bueno C, Catalina P, Melen GJ et al. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 2009;30:1628-1637.
37. Barberi T, Studer L. Mesenchymal cells. Methods Enzymol 2006;418:194-208. (Pubitemid 46068577)
38. Bielby RC, Christodoulou IS, Pryce RS et al. Time- and concentration-dependent effects of dissolution products of 58S gel bioactive glass on proliferation and differentiation of murine and human osteoblasts. Tissue Eng 2004;10:1018-1026. (Pubitemid 39223781)
39. Sottile V, Thomson A, McWhir J. In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells 2003;5:149-155.
40. Karp JM, Ferreira LS, Khademhosseini A et al. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells 2006;24:835-843. (Pubitemid 44464716)
41. Xiong C, Xie CQ, Zhang L et al. Derivation of adipocytes from human embryonic stem cells. Stem Cells Dev 2005;14:671-675. (Pubitemid 43201901)
42. Trivedi P, Hematti P. Simultaneous generation of CD34+ primitive hematopoietic cells and CD73+ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp Hematol 2007;35:146-154. (Pubitemid 46014371)
43. Olivier EN, Rybicki AC, Bouhassira EE. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells 2006;24:1914-1922. (Pubitemid 44474167)
44. Bach C, Buhl S, Mueller D et al. Leukemogenic transformation by HOXA cluster genes. Blood 2010;115:2910-2918.
45. de la Fuente R, Abad JL, Garcia-Castro J et al. Dedifferentiated adult articular chondrocytes: A population of human multipotent primitive cells. Exp Cell Res 2004;297:313-328. (Pubitemid 38798396)
46. Lee CC, Christensen JE, Yoder MC et al. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp Hematol 2010;38:46-54.
47. Menicanin D, Bartold PM, Zannettino AC et al. Identification of a common gene expression signature associated with immature clonal mesenchymal cell populations derived from bone marrow and dental tissues. Stem Cells Dev 2010;19:1501-1510.
48. Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-1166. (Pubitemid 30229533)
49. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010;107:4335-4340.